Nefopam Hydrochloride Accord-Uk (Nefopam Hydrochloride)

The drug inhibits the reuptake of three key neurotransmitters—serotonin, norepinephrine and dopamine—within the central nervous system. By increasing their levels, it enhances descending inhibitory pathways that dampen pain signal transmission, providing analgesia through a multimodal mechanism.

The appropriate dose of Nefopam Hydrochloride Accord-Uk is determined by the prescribing clinician based on the individual’s medical condition, severity of pain, age, renal and hepatic function, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of Nefopam Hydrochloride in pregnancy and lactation has not been definitively established. It is classified as a pregnancy category with unknown risk, so it should only be used if the potential benefit justifies any possible fetal or infant exposure, and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike opioids, Nefopam does not act on opioid receptors and therefore carries a lower risk of respiratory depression, dependence and constipation. Its analgesic effect is achieved through neurotransmitter reuptake inhibition, making it a useful alternative for patients who need moderate pain relief without opioid‑related side effects.

Nefopam Hydrochloride Accord-Uk should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The medication is formulated for oral administration. Patients should swallow the tablet or capsule whole with a glass of water, unless otherwise directed by a healthcare professional. It is usually taken with or without food, as advised by the prescriber.

Serious adverse events, although rare, include tachycardia, severe hypotension, seizures and allergic reactions such as rash, itching or swelling. Patients should seek immediate medical attention if they experience any of these symptoms while taking the drug.

Individuals with a known hypersensitivity to nefopam or any of its excipients, those taking monoamine oxidase inhibitors, patients with uncontrolled hypertension, seizure disorders, or severe hepatic impairment should avoid using this medication unless a specialist determines it is safe.